Skip to main content

Yolanda Villena Ortiz

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Yolanda Villena Ortiz

Yolanda Villena Ortiz

Yolanda Villena Ortiz

Institutions of which they are part

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Técnicas diagnósticas amb Targeted proteomics

IP: Joan López Hellin, Yolanda Villena Ortiz

Investigación e implementación clínica de nuevos biomarcadores

IP: Yolanda Villena Ortiz

Projects

Antimicrobianos nebulizados en receptores de trasplante pulmonar

IP: Ibai Los Arcos Bertiz
Collaborators: M Teresa Martin Gomez, Yolanda Villena Ortiz, Javier Gomis Rodriguez, Joan Gavaldà Santapau, Judith Sacanell Lacasa, Marta Zapata Ortega, Leire Sanchez Corujo
Funding agency: Instituto de Salud Carlos III
Funding: 37500
Reference: PI23/01467
Duration: 01/01/2024 - 31/12/2026

Cálculo de intervalos de referencia para magnitudes biológicas empleando un método indirecto

IP: Yolanda Villena Ortiz
Collaborators: -
Funding agency: FUNDACIÓN JOSÉ LUIS CASTAÑO
Funding: 6000
Reference: SEQC 001
Duration: 01/07/2023 - 01/07/2024

Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT)

IP: Ibane Abasolo Olaortua
Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Laura Conesa Milian, Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Diego Baranda Martínez-Abasca, Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Noelia Díaz Troyano, JAUME VIMA BOFARULL, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Maria Francesca Cortese, Sandra Mancilla Zamora
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 01173
Duration: 01/01/2022 - 30/06/2025

Estudio de validación de una aplicación para Smartphone (NORA) en pacientes con enfermedad renal diabética avanzada. Efecto en la progresión de la enfermedad renal y la mortalidad cardiovascular en época COVID.

IP: Maria Jose Soler Romeo
Collaborators: Yolanda Villena Ortiz, Joan López Hellin
Funding agency: Sociedad Española de Nefrología (S.E.N.)
Funding: 24000
Reference: SENEFRO/PROJECTES/2021/SOLER
Duration: 15/07/2021 - 14/01/2023

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The European Rare Diseases Research Alliance (ERDERA) kicked off this September, with an estimated budget of 380 million euros and the aim of improving the lives of 30 million rare disease patients in Europe and beyond.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Related professionals

Mireia Andres Villarreal

Mireia Andres Villarreal

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Buxo Masip

Xavier Buxo Masip

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Miriam Asensio Tapias

Miriam Asensio Tapias

Research technician
Biomedical Research in Gynaecology
Read more
Sebastian Lazaro

Sebastian Lazaro

Research technician
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.